Michael Kersten

476 total citations
13 papers, 389 citations indexed

About

Michael Kersten is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Michael Kersten has authored 13 papers receiving a total of 389 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 3 papers in Pulmonary and Respiratory Medicine and 3 papers in Oncology. Recurrent topics in Michael Kersten's work include Immunotherapy and Immune Responses (3 papers), Cancer Immunotherapy and Biomarkers (3 papers) and RNA modifications and cancer (2 papers). Michael Kersten is often cited by papers focused on Immunotherapy and Immune Responses (3 papers), Cancer Immunotherapy and Biomarkers (3 papers) and RNA modifications and cancer (2 papers). Michael Kersten collaborates with scholars based in Germany, Netherlands and United States. Michael Kersten's co-authors include Alois Harder, Florry A. Vyth‐Dreese, Johan Sein, W J Nooijen, Marion Horsch, Martin Hrabě de Angelis, Tripti Halder, F. Lottspeich, Johannes Beckers and D. Batchelor and has published in prestigious journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and British Journal of Cancer.

In The Last Decade

Michael Kersten

12 papers receiving 374 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael Kersten Germany	11	176	87	76	67	53	13	389
Margaret C. Neville United States	10	266 1.5×	75 0.9×	48 0.6×	59 0.9×	34 0.6×	14	699
Louise Alldridge United Kingdom	11	392 2.2×	115 1.3×	178 2.3×	64 1.0×	112 2.1×	23	705
Joshua D.G. Leach United Kingdom	8	270 1.5×	99 1.1×	91 1.2×	36 0.5×	97 1.8×	14	532
Josphin Johnson Australia	8	139 0.8×	27 0.3×	31 0.4×	18 0.3×	112 2.1×	8	354
Ricardo Sánchez Spain	13	300 1.7×	118 1.4×	38 0.5×	19 0.3×	48 0.9×	37	541
Stéphanie Dubois Canada	11	154 0.9×	92 1.1×	74 1.0×	25 0.4×	22 0.4×	14	435
Paula Kaplan United States	12	249 1.4×	82 0.9×	20 0.3×	176 2.6×	100 1.9×	17	562
Xiaojiao Zheng China	14	296 1.7×	66 0.8×	106 1.4×	24 0.4×	124 2.3×	30	536
Zhangming Chen China	12	130 0.7×	67 0.8×	81 1.1×	59 0.9×	73 1.4×	47	413
Francisco Gómez‐Esquer Spain	10	243 1.4×	40 0.5×	46 0.6×	15 0.2×	58 1.1×	32	437

Countries citing papers authored by Michael Kersten

Since Specialization

Citations

This map shows the geographic impact of Michael Kersten's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Kersten with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Kersten more than expected).

Fields of papers citing papers by Michael Kersten

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Kersten. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Kersten. The network helps show where Michael Kersten may publish in the future.

Co-authorship network of co-authors of Michael Kersten

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Kersten. A scholar is included among the top collaborators of Michael Kersten based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Kersten. Michael Kersten is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Kogan, Alexis Coulourides, et al.. (2020). Engaging Primary Care Physicians to Refer Patients to Home-Based Palliative Is Challenging and Complicated. SHILAP Revista de lepidopterología. 1(1). 259–263. 7 indexed citations

Cox, Cathy R., et al.. (2017). Ebola salience, death-thought accessibility, and worldview defense: A terror management theory perspective. Death Studies. 41(9). 585–591. 32 indexed citations

Abeyta, Andrew A., Clay Routledge, Michael Kersten, & Cathy R. Cox. (2016). The existential cost of economic insecurity: Threatened financial security undercuts meaning. The Journal of Social Psychology. 157(6). 692–702. 16 indexed citations

Dahouk, Sascha Al, Séverine Loisel‐Meyer, Holger C. Scholz, et al.. (2009). Proteomic analysis of Brucella suis under oxygen deficiency reveals flexibility in adaptive expression of various pathways. PROTEOMICS. 9(11). 3011–3021. 27 indexed citations

Lichtenfels, Rudolf, Monica Zobawa, Christian V. Recktenwald, et al.. (2009). Systematic Comparative Protein Expression Profiling of Clear Cell Renal Cell Carcinoma. Molecular & Cellular Proteomics. 8(12). 2827–2842. 24 indexed citations

Keidel, Eva‐Maria, et al.. (2006). Protein isoforms in cancer, identified and quantified by the ICPL (isotope-coded protein labelling) technology. Max Planck Institute for Plasma Physics. 5. 1 indexed citations

Kersten, Michael, Monica Zobawa, Alois Harder, et al.. (2005). Identification of Dll1 (Delta1) target genes during mouse embryogenesis using differential expression profiling. Gene Expression Patterns. 6(1). 94–101. 20 indexed citations

Seliger, Barbara, Rudolf Lichtenfels, Derek Atkins, et al.. (2005). Identification of fatty acid binding proteins as markers associated with the initiation and/or progression of renal cell carcinoma. PROTEOMICS. 5(10). 2631–2640. 36 indexed citations

Harder, Alois, Tripti Halder, Michael Kersten, et al.. (2005). Identification of coexpressed gene clusters in a comparative analysis of transcriptome and proteome in mouse tissues. Proceedings of the National Academy of Sciences. 102(24). 8621–8626. 73 indexed citations

10.

Batchelor, D., Michael Kersten, Florry A. Vyth‐Dreese, et al.. (2003). Temozolomide followed by combined immunotherapy with GM-CSF, low-dose IL2 and IFNα in patients with metastatic melanoma. British Journal of Cancer. 88(2). 175–180. 36 indexed citations

11.

Jansen, Slinger, Gerard Groenewegen, Henk Mallo, et al.. (2003). Immunotherapy with concurrent subcutaneous GM-CSF, low-dose IL-2 and IFN-α in patients with progressive metastatic renal cell carcinoma. British Journal of Cancer. 88(9). 1346–1351. 30 indexed citations

12.

Seliger, Barbara, Rudolf Lichtenfels, Derek Atkins, et al.. (2003). Identification of markers for the selection of patients undergoing renal cell carcinoma‐specific immunotherapy. PROTEOMICS. 3(6). 979–990. 39 indexed citations

13.

Gast, G C de, Heinz‐Josef Klümpen, Florry A. Vyth‐Dreese, et al.. (2000). Phase I trial of combined immunotherapy with subcutaneous granulocyte macrophage colony-stimulating factor, low-dose interleukin 2, and interferon alpha in progressive metastatic melanoma and renal cell carcinoma.. PubMed. 6(4). 1267–72. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact